Amgen may see $3B+ in additional taxes; EQRx, AbCellera ink antibody development deal

Alongside the release of its Q2 results late Tuesday, Amgen also signaled that it’s defending what could be a sizeable chunk of cash that it owes the IRS.

Last month, the company said it filed a petition in the US Tax Court to contest notices of deficiencies received from the...

Click to view original post